Kerala man, who received Covaxin vaccine, gets Covaxin in second dose \
1 min read
\
\

Kerala man, who received Covaxin vaccine, gets Covaxin in second dose

27-Jul-2021
Wayanad (Kerala) [India], July 27 (ANI): An elderly man who received the first dose of Covaxin was allegedly administered Covishield in his second dose at Mananthavady here.
27-Jul-2021 National
\
Results of Covaxin trials on children likely by September, AIIMS Director said \
1 min read
\
\

Results of Covaxin trials on children likely by September, AIIMS Director said

24-Jul-2021
According to AIIMS director Dr Guleria, results of the Covaxin trials on children can be expected in September.  Trials of Bharat Biotech’s Covaxin on children are currently underway, with the second dose of the Covid-19 vaccine likely to be administered to children aged 2-6 years next week. Also Read Bharat Biotech terminates MoU with Brazilian partners amid corruption allegations […]
24-Jul-2021 Coronavirus
\
Bharat Biotech cancels contracts with 2 Brazil firms for Covaxin \
2 min read
\
\

Bharat Biotech cancels contracts with 2 Brazil firms for Covaxin

23-Jul-2021
New Delhi [India], July 23 (ANI): Bharat Biotech on Friday said it has terminated agreements it had signed with two Brazilian companies - Precisa Medicamentos and Envixia Pharmaceuticals LLC to introduce its Covid-19 Covaxin in Brazil.
23-Jul-2021 Coronavirus
\
COVID-19: Second dose trial of Covaxin on 2-6 years to begin by next week \
2 min read
\
\

COVID-19: Second dose trial of Covaxin on 2-6 years to begin by next week

23-Jul-2021
New Delhi [India], July 23 (ANI): As part of its COVID-19 vaccination trials for children, Bharat Biotech is likely to administer the second dose of Covaxin to children aged between 2 and 6 years next week, sources said on Thursday.
23-Jul-2021 Coronavirus
\
Bharat Biotech dossier under review for Covaxin emergency use listing: WHO \
4 min read
\
\

Bharat Biotech dossier under review for Covaxin emergency use listing: WHO

19-Jul-2021
New Delhi [India], July 19 (ANI): Officials of the World Health Organisation (WHO) had a meeting with those of Bharat Biotech and the Hyderabad-based vaccine maker's dossier for Emergency Use Listing (EUL) of Covaxin is under review by the technical experts for consideration, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said on Monday.
19-Jul-2021 Coronavirus
\
Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech \
1 min read
\
\

Will receive EUL for Covaxin from WHO at earliest, says Bharat Biotech

12-Jul-2021
Hyderabad (Telangana) [India], July 12 (ANI): With a review process of 'Covaxin', the indigenous vaccine against COVID-19 commencing at the World Health Organisation (WHO), the Hyderabad-based Bharat Biotech on Monday said it expects to receive emergency use listing (EUL) from the global body at the earliest.
12-Jul-2021 Coronavirus
\
EUL to Covaxin from WHO expected in first week of August: Sources \
1 min read
\
\

EUL to Covaxin from WHO expected in first week of August: Sources

10-Jul-2021
Geneva [Switzerland], July 10 (ANI): The World Health Organisation (WHO) is likely to take a decision on Emergency Use Listing (EUL) of Bharat Biotech's Covaxin and announce it in the first week of August.
10-Jul-2021 Coronavirus
\
With a day of Covaxin stock left, Punjab CM calls for more supplies from Centre \
1 min read
\
\

With a day of Covaxin stock left, Punjab CM calls for more supplies from Centre

09-Jul-2021
Chandigarh (Punjab) [India], July 9 (ANI): Punjab Chief Minister Captain Amarinder Singh on Friday reiterated the need for an increase in COVID-19 vaccine supply from the Centre.
09-Jul-2021 Coronavirus
\
Brazilian Supreme Court approves investigation of Bolsonaro over Covaxin deal: Reports \
1 min read
\
\

Brazilian Supreme Court approves investigation of Bolsonaro over Covaxin deal: Reports

03-Jul-2021
Buenos Aires [Argentina], July 3 (ANI/Sputnik): The Supreme Federal Court of Brazil has approved a probe into President Jair Bolsonaro regarding alleged overpricing during the purchase of India's coronavirus vaccine Covaxin, the G1 website reported.
03-Jul-2021 Coronavirus
\
After release of Covaxin’s phase 3 efficacy data, NTAGI chief says it will help vaccine get WHO recognition \
2 min read
\
\

After release of Covaxin’s phase 3 efficacy data, NTAGI chief says it will help vaccine get WHO recognition

03-Jul-2021
New Delhi [India], (ANI): Hours after Bharat Biotech announced that its vaccine Covaxin's efficacy against COVID-19 is 77.8 per cent, National Technical Advisory Group on Immunisation (NTAGI) Chief Dr NK Arora said that these results will help the vaccine get recognition from the World Health Organisation (WHO).
03-Jul-2021 Coronavirus
\